First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland (2021)
Attributed to:
Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41591-021-01408-4
PubMed Identifier: 34108714
Publication URI: http://europepmc.org/abstract/MED/34108714
Type: Journal Article/Review
Parent Publication: Nature Medicine
Issue: 7
ISSN: 1078-8956